Plus-Size Model Mia Amber Davis' Widower Files Suit

He alleges that Davis died because she was too obese to be on birth control pills.

Posted:
 
miaamberdavisdead_42812_400
Mia Amber Davis (Plus Model)

The widower of plus-size model Mia Amber Davis, known for her cameo in the movie Road Trip, her work with Ashley Stewart as the face of Jill Scott's Butterfly Bra and her role as creative editor-at-large for Plus Model magazine, has filed a suit against her doctors, TMZ reports.

Davis, who died last year of pulmonary embolism at the age of 36, was too obese to be prescribed birth control pills, he alleges.

TMZ reports:

Mia passed away back in May 2011 as a result of a pulmonary embolism ... one day after undergoing knee surgery.

But in his lawsuit, Mia's widower claims ... in the months before the surgery, Mia's OBGYN prescribed her birth control pills such as Balziva and Zenchent ... "drugs that greatly increase one's risk for a pulmonary embolism, especially when combined with [Mia's] other risk factors."

Mia's widower lists "obesity" as one of Mia's significant risk factors.

Mia's widower claims his wife's doctor SHOULD HAVE suggested condoms or other methods of birth control as an alternative ... because the drugs "greatly increased her risk for a pulmonary embolism and ultimately caused her death."

To make matters worse, Mia's widower claims Mia went to a family practitioner on April 18 to complain about knee pain. The doc allegedly cleared Mia for knee surgery ... despite a number of risk factors, including obesity, hyperlipidemia and the fact she was on Zenchent. 

Mia's widower claims the doc "should have advised [Mia] to eliminate some of her other risk factors prior to clearing her for the surgery."

Read more at TMZ.

Like The Root on Facebook. Follow us on Twitter.  

Comments
The Root encourages respectful debate and dialogue in our commenting community. To improve the commenting experience for all our readers we will be experimenting with some new formats over the next few weeks. During this transition period the comments section will be unavailable to users.

We apologize for any inconvenience and appreciate your continued support of The Root.

While we are experimenting, please feel free to leave feedback below about your past experiences commenting at The Root.